Endometrial Biopsy Prior to IVF in Those Patients With Prior Implantation Failure (EMBX/IVF)

S

Shady Grove Fertility Reproductive Science Center

Status

Unknown

Conditions

Infertility
Implantation Failure

Treatments

Procedure: Sham Procedure
Procedure: Endometrial Biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT01800513
SGFRSC EMBX 2013

Details and patient eligibility

About

This proposed research is a single center, prospective, single-blinded, randomized controlled trial, designed to evaluate IVF pregnancy outcomes following endometrial injury in 254 patients with implantation failure. Patients will be identified during their work-up and treatment at Shady Grove Fertility Reproductive Science Center. Only Shady Grove patients are eligible for the study. The investigators hypothesize in patients with one or more previous failed day 5 blastocyst transfers, injury to the endometrium via endometrial biopsy will improve clinical pregnancy outcomes compared to controls.

Full description

Despite advances in assisted reproductive technologies; implantation failure in patients undergoing in-vitro fertilization (IVF) is frequent. Unfortunately, few treatments exist except for the use of a gestational carrier. There have been a number of recent clinical studies demonstrating that local injury to the endometrium results in improved clinical pregnancy outcomes for patients with a history of implantation failure. However, not all studies have shown a beneficial effect, and those demonstrating benefit have been limited by small sample sizes, and considerable heterogeneity in the procedures and populations evaluated. A recent meta-analysis synthesized the available data concluded that a large, prospective, well-designed randomized trial is desperately needed to definitively assess this new possible treatment. If these preliminary findings from previous trials are confirmed, this practice could be applied in the clinical setting to help patients suffering from repeated implantation failures.

Enrollment

254 estimated patients

Sex

Female

Ages

18 to 37 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women age 18-37
  • One or more previous implantation failures with autologous fresh or frozen blastocyst transfer
  • Undergoing fresh autologous IVF cycle
  • No other current uterine (i.e.: uterine fibroids, polyps), hematologic, or genetic causes for infertility and implantation failure
  • One or more good quality blastocyst(s) available for transfer

Exclusion criteria

  • Those unable to comprehend the investigational nature of the proposed study
  • Positive pregnancy test
  • Possible causes for impaired implantation (systemic disease, endometriosis, ultrasound evidence of current hydrosalpinx, uterine polyps, uterine myomas (fibroids), uterine cavity malformations or Asherman's syndrome)
  • Poor responders, defined as FSH >12 on day 3 or less than 4 follicles on a previous IVF cycle
  • BMI >30 or <18

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

254 participants in 2 patient groups

Endometrial Biopsy
Experimental group
Description:
Subjects will have a vaginal speculum placed and visualization of the cervix will be obtained. The cervix will be cleaned with betadine (or hibiclens for those with an iodine allergy). Those randomized to the treatment arm (endometrial biopsy) will have an endometrial pipelle (Endocell, Wallach, Orange, Connecticut) inserted gently through the cervix into the uterus. Two passes will be performed with the pipelle catheter. For each pass the catheter will be rotated and scraped 4 times, once in each quadrant.
Treatment:
Procedure: Endometrial Biopsy
Control
Sham Comparator group
Description:
Those randomized to the control group will have a small cotton swab placed gently into the cervix. No tissue will be obtained with this method. The randomization to a placebo control is necessary to prove that any positive effects seen are due to the biopsy and not just random chance.
Treatment:
Procedure: Sham Procedure

Trial contacts and locations

1

Loading...

Central trial contact

Erin F Wolff, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems